Koers TruTrace Technologies Inc Canadian Securities Exchange
Aandelen
CA8984471075
Geavanceerde medische apparatuur & technologie
Omzet 2021 | 0,16 0,22 0,15 | Omzet 2022 | 0,12 0,16 0,11 | Marktkapitalisatie | 3,82 mln. 5,19 mln. 3,51 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -1 mln. -1,36 mln. -919K | Nettowinst (verlies) 2022 | -2 mln. -2,72 mln. -1,84 mln. | EV/omzet 2021 | 83.773.009 x |
Nettoliquiditeiten 2021 | 893K 1,21 mln. 821K | Nettoschuld 2022 | 681K 926K 626K | EV/omzet 2022 | 37.973.468 x |
K/w-verhouding 2021 |
-6,71
x | K/w-verhouding 2022 |
-1,64
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 87,1% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 11-10-11 | |
Robert Lelovic
DFI | Director of Finance/CFO | - | 16-06-21 |
James LaValle
CTO | Chief Tech/Sci/R&D Officer | - | 21-03-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Cesare Fazari
BRD | Director/Board Member | - | 09-03-20 |
Robert Galarza
BRD | Director/Board Member | 45 | 17-05-18 |
Allan O'Dette
CHM | Chairman | - | 06-11-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,02% | 32,94 mld. | |
+21,53% | 7,83 mld. | |
+36,69% | 4,26 mld. | |
-28,73% | 2,74 mld. | |
-19,64% | 1,39 mld. | |
-26,79% | 1,27 mld. | |
-32,48% | 1,17 mld. | |
+13,61% | 988 mln. | |
-37,86% | 884 mln. |